Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: safety and efficacy results from a randomised phase 3 trial (pathfinder™2)
XXVI Congress of the International Society on Thrombosis and Haemostasis and 63rd Annual Scientific and Standardization Committee meeting, 8 - 13 Temmuz 2017, cilt.1, ss.730, (Özet Bildiri)